Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era

Patients and physicians may defer unrelated donor hematopoietic cell transplantation (HCT) as curative therapy due to mortality risk associated with the procedure. Therefore, it is important for physicians to know the current outcomes data when counseling potential candidates. To provide this inform...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Majhail, Navneet S, Chitphakdithai, Pintip, Logan, Brent, King, Roberta, Devine, Steven, Rossmann, Susan N, Hale, Gregory, Hartzman, Robert J, Karanes, Chatchada, Laport, Ginna G, Nemecek, Eneida, Snyder, Edward L, Switzer, Galen E, Miller, John, Navarro, Willis, Confer, Dennis L, Levine, John E
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4272902/
https://ncbi.nlm.nih.gov/pubmed/25445638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.10.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi